Drug intelligence / Profile preview

Noax Uno

Development stage
Unknown
Lead developer
Gebro Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Noax Uno is an extended-release oral formulation of tramadol, a synthetic opioid analgesic. It is designed for once-daily administration to manage moderate to severe chronic pain that requires continuous, long-term opioid therapy. Tramadol, the active ingredient, exerts its effects through a dual mechanism: it acts as a mu-opioid receptor agonist and inhibits the neuronal reuptake of norepinephrine and serotonin. This formulation allows for stable plasma concentrations over a 24-hour period, improving patient compliance and providing consistent analgesia. It is typically available in strengths ranging from 100 mg to 400 mg and must be swallowed whole to maintain its controlled-release profile.

Brand names
Noax Uno
Other names
Tramadol extended-releaseTramadol retard
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)NaV (Voltage-gated sodium channels)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Noax Uno.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noax Uno.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call